Baotou Dongbao Bio-Tech Co.,Ltd provided earnings guidance for the first three quarter of 2014. For the period, the company expected net profit attributable to shareholders to be in the range of CNY 2.6 million to CNY 4 million, declining 88.16% to 92.31% from CNY 33.7926 million a year earlier.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.7 CNY | -1.67% |
|
+1.08% | -24.56% |
May. 24 | Baotou Dongbao Bio-Tech Co.,Ltd Announces 2023 Final Cash Distribution Plan on A Shares, Payable on 31 May 2024 | CI |
May. 15 | Baotou Dongbao Bio-Tech Co.,Ltd Approves Management Appointments | CI |
1st Jan change | Capi. | |
---|---|---|
-24.56% | 385M | |
+26.27% | 45.54B | |
+34.60% | 24.51B | |
+26.79% | 16.48B | |
+21.95% | 14.66B | |
+72.98% | 14.3B | |
-0.05% | 6.79B | |
-11.53% | 6.73B | |
+18.15% | 5.87B | |
-8.87% | 5.73B |
- Stock Market
- Equities
- 300239 Stock
- News Baotou Dongbao Bio-Tech Co.,Ltd
- Baotou Dongbao Bio-Tech Co.,Ltd Provides Earnings Guidance for the First Three Quarter of 2014